Does Tufts Health Plan cover ketamine therapy or ketamine treatment?

Logo for Tufts Health Insurance Plan, covering esketamine and Spravato therapy in the Boston and Bethesda, MD area for treatment-resistant depression, anxiety, and other mental health conditions

Latest medical review on: May 5th, 2026. Medically reviewed by Instructor in Psychiatry at Harvard Medical School and Lumin Health Co-founder, Chief Medical Officer Dr. Ben Yudkoff.

Does Lumin Health accept Tufts Health Plan for Spravato treatment?

Lumin Health is currently out-of-network with Tufts Health Plan, so Tufts insurance cannot be billed directly for ketamine therapy or Spravato at Lumin. Tufts members can still access care through out-of-network reimbursement, the Spravato medical-benefit pathway, or self-pay options — see below for the specific routes.

We are grateful for your interest in starting treatment with us and apologize for not being able to accept Tufts Health Plans.

Are there other resources Lumin Health can recommend?

While each institution sets their own insurance acceptance policy, we always recommend that prospective patients reach out to the large hospital networks such as Faulkner Hospital, Massachusetts General Hospital, and McLean.

Frequently asked questions

Article Reviewed by Dr. Benjamin Yudkoff, MD, MA
Dr. Yudkoff is a board-certified psychiatrist who provides the most up-to-date psychiatric care to people managing illnesses that have not satisfactorily resolved with treatment as usual, and in a way which honors principles of autonomy, self-direction, and holistic approaches. He has lectured on spirituality and ketamine therapy, is an Instructor in Psychiatry at Harvard Medical School, and has taught a humanism course to residents of the Harvard Brigham and Women’s Hospital Residency Training Program. Dr. Yudkoff has served as the Medical Director of the Brigham and Women’s Faulkner Hospital and the Medical Director of the Interventional Psychiatric Service (electroconvulsive therapy, ketamine, and esketamine). Dr. Yudkoff has published scientific articles on ketamine and psychopharmacology, and has won several teaching awards from Harvard Medical School students and Brigham and Women’s Psychiatric Residents.